Status:
COMPLETED
Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Infections with HIV-1 group O are found in 1 to 3 % of persons living with HIV in Cameroon. The natural history and treatment response is not well understood. The natural resistance to non nucleoside ...
Eligibility Criteria
Inclusion
- HIV-1 group O or group M infection
- No history of antiretroviral treatment (except for PMTCT)
- Criteria for treatment initiation according to the Cameroons national guidelines
Exclusion
- Ongoing traditional treatment which could interfere with hepatic function
- Ongoing treatment with rifabutin, rifampicin or rifampin
- Acute hepatitis B infection
- Pregnancy or lactating mother
- HIV-1 group O and group M co-infection
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT00658346
Start Date
June 1 2010
End Date
September 1 2016
Last Update
January 12 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Central
Yaoundé, Cameroon
2
Hôpital de la CNPS
Yaoundé, Cameroon